Advances in Pharmacogenetics and Pharmacogenomics
- 1 September 2000
- journal article
- review article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 40 (9), 930-938
- https://doi.org/10.1177/00912700022009666
Abstract
Large differences among normal human subjects in the efficacy and safety of many therapeutic agents are caused by genetically controlled polymorphisms of drug‐metabolizing enzymes, drug transporters, and drug receptors. Development of pharmacogenomics as a new field has accelerated progress in pharmacogenetics by elucidating at the level of the human genome the inherited basis for those large interindividual variations. Examples discussed in this review illustrate how this approach can be used not only to guide new drug discovery but also to individualize therapy. Adverse drug reactions, often attributable to large differences among subjects in drug response, constitute a leading cause of death in the USA. Such high morbidity and mortality could be reduced by application of the principles of pharmacogenetics and pharmacogenomics, defined broadly as the study of genetically caused variability in drug response.Keywords
This publication has 45 references indexed in Scilit:
- Pharmacological Rescue of Mutant p53 Conformation and FunctionScience, 1999
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJCI Insight, 1999
- Influence of the Genotype on the Clinical Course of the Long-QT SyndromeNew England Journal of Medicine, 1998
- Influence of the Angiotensin II Type 1 Receptor Gene Polymorphism on the Effects of Perindopril and Nitrendipine on Arterial Stiffness in Hypertensive IndividualsHypertension, 1996
- Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor geneThe Lancet, 1996
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.JCI Insight, 1990
- Genetic control of dicumarol levels in manJCI Insight, 1968
- Genetic Control of Drug Levels in Man: PhenylbutazoneScience, 1968